ILLUMINA INC (ILMN)
US4523271090 - Common Stock
ILLUMINA INC
NASDAQ:ILMN (12/20/2024, 8:18:20 PM)
After market: 136.5 +0.48 (+0.35%)136.02
+2.02 (+1.51%)
Company Profile
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 10,590 full-time employees. The company went IPO on 2000-06-28. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. The company is also a developer of an emerging and highly differentiated single-cell technology.
Company Info
ILLUMINA INC
5200 Illumina Way
San Diego CALIFORNIA 92122
P: 18582024500
CEO: Francis A. deSouza
Employees: 10615
Website: https://www.illumina.com
ILMN News
5 days ago - CNBCSuper Micro slides 7% after stock is dropped from Nasdaq 100Super Micro is exiting the Nasdaq 100 after just five months in the index.
5 days ago - Yahoo FinanceWhat's Going On With Illumina Stock On Monday?On Friday, Nasdaq Inc’s (NASDAQ:NDAQ) annual reconstitution of the Nasdaq-100 Index will become effective before the market opens on December 23. Illumina, Inc. (NASDAQ:ILMN) was removed from the index. Year to date, the stock has increased around 8%, underperforming iShares Core S&P Mid-Cap ETF (NYSE:IJH). The provider of DNA sequencing and array-based technologies has been in the news due to its controversial multi-billion dollar deal to acquire cancer test maker Grail Inc (NASDAQ:GRAL). Also
8 days ago - The Motley FoolPalantir Stock Is Joining the Nasdaq-100 Index, and Super Micro Computer Is Being Booted: What Investors Should KnowPalantir stock's huge rise this year has earned it a spot on another stock index.
8 days ago - BloombergMicroStrategy, Palantir Added to Nasdaq 100, Moderna RemovedMicroStrategy Inc., the dot-com-era software maker whose metamorphosis into a leveraged bet on Bitcoin has transfixed Wall Street, is joining the Nasdaq 100 Index, the benchmark’s overseer said Friday. Software company Palantir Technologies Inc. and Axon Enterprise Inc., a maker of Tasers and police body cameras, will also be added.
8 days ago - Yahoo FinancePalantir, MicroStrategy, and Axon Enterprise To Join Nasdaq 100Palantir, MicroStrategy, and Axon Enterprise are set to join the Nasdaq 100 Index on Monday, Dec. 23, replacing Super Micro Computer, Moderna, and Illumina.
17 days ago - Illumina, Inc.Illumina To Webcast Upcoming Investor Conference/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: 43rd Annual J.P....
ILMN Twits
Here you can normally see the latest stock twits on ILMN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
